Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GreenLight invests in RNA R&D for agriculture

by Michael McCoy
January 23, 2022 | A version of this story appeared in Volume 100, Issue 3

 

GreenLight Biosciences plans to expand its operation in Research Triangle Park, North Carolina, where it researches use of RNA-based products for insect, fungus, and weed control. The firm is adding a greenhouse and labs and says it will have 60 employees there by the end of the year. GreenLight expects its first product, for controlling the Colorado potato beetle, to win US approval this year. It will go public in the coming months by merging with a special purpose acquisition company in a deal that could value it at $1.2 billion.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.